Medications & Supplements/Prescription Drugs

Preferred Pharmaceuticals Allopurinol Tablets Recalled for Plastic Contamination

Agency Publication Date: January 23, 2023

Summary

Preferred Pharmaceuticals, Inc. has recalled 9 bottles of Allopurinol (100mg) tablets, USP, due to a report of a small piece of green plastic embedded in a tablet. Allopurinol is a prescription medication used to treat gout and certain types of kidney stones. This recall affects 90-count bottles distributed through The Physician's Solution in Indiana with lot number K3022Q.

Risk

The presence of foreign plastic in a medication tablet poses a potential risk of injury to the mouth, throat, or digestive tract if swallowed, or a choking hazard. No injuries have been reported to date.

What You Should Do

This recall affects 90-count bottles of Allopurinol Tablets 100mg, USP, distributed by Preferred Pharmaceuticals, Inc. and The Physician's Solution with lot number K3022Q (expiration date 3/31/2025) and product number 68788-7383-09.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Preferred Pharmaceuticals, Inc. for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Allopurinol Tablets (90-count bottle)

Variants: 100mg, Tablet

Model:

68788-7383-09

Lot Numbers:

K3022Q (Exp 3/31/2025)

NDC:

68788-7383-09

Manufactured by Accord Healthcare, Inc; Repackaged by Preferred Pharmaceuticals, Inc.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 91531

Status: Resolved

Manufacturer: Preferred Pharmaceuticals, Inc.

Sold By: The Physician's Solution

Manufactured In: United States

Units Affected: 9 bottles

Distributed To: Indiana

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects 90-count bottles of Allopurinol Tablets 100mg, USP, distributed by Preferred Pharmaceuticals, Inc. and The Physician's Solution with lot number K3022Q (expiration date 3/31/2025) and product number 68788-7383-09.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Preferred Pharmaceuticals, Inc. for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.